Delivery Order SPE2DB20D7066-SPE2DB25FC3PF
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $58,094.55 delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Synvisc-One syringes (6ML, 1 unit). The contract is non-competitive, firm fixed-price delivery order with an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a $11,011.74 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Synvisc-One syringes (6ml). This firm fixed-price contract, with a completion date of November 26, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award carries no set-aside designation, indicating it was competitively awarded. Performance will occur at...
- The Defense Logistics Agency awarded a $7,898.36 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Synvisc-One syringes (6mL), with completion targeted for September 9, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $37,796.56 to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6 milliliters, quantity 1) with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by February 17, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare...
- The Defense Logistics Agency awarded a $7,258.08 delivery order to AmerisourceBergen Drug Corp for Synvisc-One syringes (6mL, 1 unit) with an ultimate completion date of January 14, 2026. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Synvisc-One Syringes (6 mL) with a ceiling value of $1,432.08. This competitive, non-set-aside award utilizes firm fixed pricing and is scheduled for completion by September 19, 2025. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This is a firm fixed price delivery order with a ceiling value of $6,009.24 and an ultimate completion date of July 2, 2025. The contract represents a non-competitive award utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,985.24 to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6ml). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Synvisc-One is a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Synvisc-One syringes (6mL) with a ceiling value of $3,885.12 under a firm fixed-price contract type. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $19,398.41 on July 29, 2025, for the supply of Synvisc-One syringes (6mL, 1 unit). This firm fixed-price, competitively awarded delivery order is scheduled for completion by August 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract requires no set-aside designation. This delivery order is issued under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3PFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13.8K to AmerisourceBergen Drug Corp for Synvisc-One syringes (6mL) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1B vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. Synvisc-One is a viscosupplement injection used for osteoarthritis pain management, and this delivery order fulfills federal medical supply requirements through AmerisourceBergen's extensive pharmaceutical distribution network. As a major healthcare solutions provider and critical vendor for military and veteran healthcare systems, AmerisourceBergen has demonstrated capability to meet federal procurement requirements across a diverse portfolio of medications and medical supplies. This award exemplifies the company's role in supporting DLA's medical supply chain and reflects ongoing federal reliance on AmerisourceBergen for specialty pharmaceutical delivery to defense healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 6/2/25 |